GL1X · GenesisL1 explorer

Research workbench

Anti-CRISPR associated (aca) protein, ACA2

Analyse Anti-CRISPR associated (aca) protein, ACA2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7B5J
Type
protein
Length
230 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Anti-CRISPR associated (aca) protein, ACA2
UniProt
H9C180
Pockets
3 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BAnti-CRISPR associated (aca) protein, ACA2protein11567% helix, 3% strandH9C180

Ligands and binding sites

  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11270.450.7823empty
21070.380.7518empty
3950.360.7414empty

Interfaces

1 interface between chains.

  • A–B · 1264 Ų buried · 12 hydrogen bonds · protein-protein

Compared structures

  • 7B5J · Anti-CRISPR associated (Aca) protein, Aca2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.